Chengzhong Li Selected Research

Chengzhong Li Research Topics

3	Hepatocellular Carcinoma (Hepatoma) 06/2016 - 11/2009
2	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2024
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2020 - 11/2009
2	Neoplasms (Cancer) 01/2020 - 06/2016
2	Hepatitis 02/2014 - 09/2008
1	End Stage Liver Disease 04/2024
1	Chronic Disease (Chronic Diseases) 01/2024
1	Obesity 01/2024
1	Nausea 01/2020
1	Ascites 01/2020
1	Dizziness (Lightheadedness) 01/2020
1	Fatigue 01/2020
1	Hepatic Encephalopathy 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Infections 01/2020
1	Weight Loss (Weight Reduction) 07/2017
1	Cholestasis 08/2015
1	Liver Neoplasms (Liver Cancer) 02/2014
1	Fibrosis (Cirrhosis) 10/2010
1	Chronic Hepatitis B 10/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2009
1	Inflammation (Inflammations) 11/2009
1	Chronic Hepatitis (Chronic Active Hepatitis) 09/2008

2	BilirubinIBA 01/2020 - 08/2015
2	Hepatitis B e AntigensIBA 11/2009 - 09/2008
1	SodiumIBA 04/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	HLA-DR Antigens (HLA-DR)IBA 11/2020
1	AntigensIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	TeaIBA 01/2020
1	SugarsIBA 07/2017
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2017
1	MicroRNAs (MicroRNA)IBA 06/2016
1	Proteins (Proteins, Gene)FDA Link 06/2016
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 08/2015
1	Alkaline PhosphataseIBA 08/2015
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 02/2014
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2010
1	NucleotidesIBA 10/2010
1	Alanine Transaminase (SGPT)IBA 11/2009
1	NF-kappa B (NF-kB)IBA 11/2009

2	Liver Transplantation 01/2024 - 01/2020
2	Therapeutics 01/2024 - 01/2020
1	Radiotherapy 01/2020
1	Cytoreduction Surgical Procedures 01/2020